|
Markt geschlossen -
Nasdaq
22:00:00 04.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 7.070 USD | -2.48% |
|
+4.74% | -61.07% |
| 23.10. | Aktien von Avalo Therapeutics fallen nach Abstufung durch HC Wainwright | MT |
| 23.10. | Avalo Therapeutics, Inc. : Guggenheim gibt neutrale Einschätzung | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.48% | +4.74% | -52.84% | -60.83% | -61.07% | -57.59% | -71.48% | -99.90% | -99.93% | 389 Mio. | |
| +10.00% | +5.18% | -11.07% | +15.81% | +64.18% | +54.35% | +71.20% | +12.37% | - | 60.57 Mrd. | |
| +1.44% | +4.06% | +16.97% | +18.10% | +23.02% | +22.70% | +101.03% | -13.81% | +267.56% | 55.51 Mrd. | |
| +3.32% | +4.11% | -0.05% | +12.85% | +13.70% | +14.82% | +75.04% | +195.40% | +6’046.30% | 55.22 Mrd. | |
| +0.46% | -2.86% | +2.16% | +13.04% | +17.03% | +23.34% | +33.77% | +3.61% | +265.31% | 43.27 Mrd. | |
| +6.42% | +3.20% | +5.50% | +20.40% | +24.35% | +21.14% | +105.56% | +1.09% | +1’107.74% | 40.36 Mrd. | |
| +2.82% | +7.24% | -3.36% | +9.45% | +150.72% | +236.59% | +801.17% | +503.69% | - | 41.63 Mrd. | |
| -3.79% | +19.39% | +58.53% | +93.82% | +76.52% | +91.90% | +77.13% | +21.08% | +200.93% | 33.29 Mrd. | |
| +5.32% | +6.04% | +9.53% | +9.77% | +16.02% | +20.27% | +52.98% | +15.84% | +164.26% | 32.27 Mrd. | |
| +5.32% | +15.84% | -1.01% | +11.73% | -36.80% | -40.93% | +342.66% | +239.30% | +961.78% | 22.91 Mrd. | |
| +12.22% | +8.20% | -11.42% | +24.54% | +53.69% | +35.65% | +0.77% | -56.15% | - | 22.52 Mrd. | |
| +4.35% | +4.18% | -6.40% | -1.68% | -4.73% | -12.75% | -5.30% | -69.30% | - | 21.83 Mrd. | |
| -1.01% | -2.53% | +9.56% | +14.56% | +16.94% | +10.56% | +139.51% | +192.89% | +2’159.27% | 18.56 Mrd. | |
| +0.89% | +2.97% | +17.58% | +29.94% | +41.06% | +46.26% | +70.91% | -14.76% | +119.06% | 16.95 Mrd. | |
| +0.61% | +11.32% | +24.59% | +32.13% | +65.98% | +91.15% | +246.43% | +278.12% | +613.24% | 17.64 Mrd. | |
| +3.10% | +4.91% | +13.19% | +5.95% | - | - | - | - | - | 16.43 Mrd. | |
| -7.27% | -9.07% | +12.44% | +41.33% | +63.57% | +82.43% | +79.37% | -15.86% | +384.11% | 16.8 Mrd. | |
| -0.32% | +11.00% | +25.34% | +28.22% | +11.46% | +20.33% | -21.31% | -26.30% | +164.88% | 15.27 Mrd. | |
| +2.04% | +5.04% | +7.30% | +7.30% | +195.02% | +178.43% | +351.25% | +1’484.71% | +852.79% | 15.47 Mrd. | |
| -2.81% | +4.80% | -1.33% | +64.19% | +28.04% | -14.77% | - | - | - | 14.16 Mrd. | |
| Durchschnitt | +2.18% | +3.99% | +5.76% | +19.53% | +39.93% | +43.36% | +136.15% | +147.33% | +943.38% | 28.05 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +3.15% | +3.51% | +7.26% | +21.82% | +44.16% | +49.93% | +150.29% | +125.09% | +1’338.76% |
- Börse
- Aktien
- A3E2FR Aktie
- Sektor Avalo Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
